Clinical Trials

Showing trials with last updates posted in 2023.

NCT01709435 | COMPLETED | PHASE1
41 participants

Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-22
Start Date:
2012-11-14
Completion:
2018-12-31
Conditions
  • Recurrent Malignant Solid Neoplasm
  • Recurrent Melanoma
  • Recurrent Primary Central Nervous System Neoplasm
  • Recurrent Thyroid Gland Carcinoma
  • Refractory Malignant Solid Neoplasm
  • Refractory Primary Central Nervous System Neoplasm
  • Thyroid Gland Medullary Carcinoma
Interventions
  • DRUG
  • OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page